Next-generation rifamycins for the treatment of mycobacterial infections

AdminUncategorized1 week ago12 Views

Proceedings of the National Academy of Sciences, Volume 122, Issue 18, May 2025.
SignificanceMycobacterium abscessuslung disease is a growing global health crisis due to limited therapeutic options and emerging drug-resistant strains. To address this unmet clinical need, we are developing oral rifamycins with enhanced antibacterial …
Read More

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Leave a reply

Recent Comments

No comments to show.

Stay Informed With the Latest & Most Important News

I consent to receive newsletter via email. For further information, please review our Privacy Policy

Advertisement

Loading Next Post...
Follow
Sign In/Sign Up Sidebar Search Trending 0 Cart
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

Cart
Cart updating

ShopYour cart is currently is empty. You could visit our shop and start shopping.